Mixed Mesodermal (Mullerian) Tumor — Trials

Mixed Mesodermal (Mullerian) Tumor — Trials · CancerIndex

Clinical trials

Registered studies

24 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02364713	MV-NIS or Investigator's Choice Chemotherapy in Treating Patients With Ovarian, Fallopian, or Peritoneal Cancer	terminated	Phase 2	17	Mayo ClinicOTHER	1	Dec 11, 2025	clinicaltrials
NCT03641287	The Effects of Exercise on Distress, Quality of Life, and Biomarkers in Ovarian Cancer Survivors	terminated	N/A	64	University of WashingtonOTHER	1	Nov 29, 2023	clinicaltrials
NCT03924245	Olaparib and Entinostat in Patients With Recurrent, Platinum-Refractory, Resistant Ovarian, Primary Peritoneal, Fallopian Tube Cancers	terminated	Phase 1	3	Vanderbilt-Ingram Cancer CenterOTHER	1	Apr 4, 2022	clinicaltrials
NCT00322881	Carboplatin and Paclitaxel in Elderly Women With Newly Diagnosed Ovarian, Peritoneal, or Fallopian Cancer

Data updated 22 days agoSource updated Dec 11, 2025source: clinicaltrials